Five VA patients blinded by Avastin injections: report

	Tweet

Five patients being treated for eye disease were blinded after being injected with Roche Holding AG’s Avastin at the Los Angeles Veterans Affairs medical center, according to the New York Times.

VA officials did not respond to requests for comment.

The latest cases of blindness follow an alert from the U.S. Food and Drug Administration on Tuesday that repackaged injections of the Avastin, also known as bevacizumab, had caused serious eye infections in 12 Miami-area patients.

Avastin is a cancer drug, but is commonly used to treat the wet form of age-related macular degeneration and other eye diseases because it costs only about $50 an injection, compared with some $2,000 for Roche’s Lucentis, which is approved for treatment of eye diseases.

The company has argued for years the process of dividing up doses creates the risk of contamination.

The tainted Florida injections were traced to a single pharmacy located in Hollywood, Florida. The pharmacy repackaged the Avastin from sterile injectable 100 mg/4 ml, single-use, preservative-free vials into individual 1 ml single-use syringes.

The pharmacy then distributed the Avastin to multiple eye clinics.

In the Los Angeles cases, no contaminant has yet been identified, the Times reported.

In its alert on Tuesday, the FDA did not tell doctors to avoid using Avastin, only to be careful about contamination.

“Health care professionals should ensure that drug products are obtained from appropriate, reliable sources and properly administered,” it said.

(Reporting by Deena Beasley; editing by Andre Grenon)

###

(Reuters)

RELATED STORIES:
Grapes may help prevent age-related blindness   Woman kills herself so blind sons can see   Protein Roadmap for Inherited Eye Diseases   Merck sought to reformulate Vioxx in 2000   Cilexa safely curbs depression in the young   Scientists step closer to new treatments for river blindness   Keeping An Eye On Workplace Eye Safety   Popular colorectal cancer drug may cause permanent nerve damage   Shortfall in malaria drug causing deaths--MSF   Counterfeit Internet drugs pose significant risks and discourage vital health checks   Drug-dispensing contact lens passes early tests   Retina transplants show promise in patients with retinal degeneration

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]